Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics.

Brands and governments face a turbulent legislative landscape over the next few years, and frustrations are already intensifying.

Connector makers enhance designs to meet AI app demands while reducing noise and improving signal integrity performance ...

CMOS-built optical phase modulators shrink laser control hardware and power use for trapped atom quantum computers, enabling ...

After securing Medicare reimbursement for its pacemaker-like heart failure (HF) implant, Impulse Dynamics has raised more ...

Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical ...

Impulse Dynamics announced today that it raised more than $158 million in financing to support its heart failure treatment ...

Brain-computer interfaces will play a central role in defining how human intelligence and artificial intelligence fit together.

ENIGMA-TRS 2 is a global, randomized, double-blind, placebo-controlled 12-week Phase III clinical study designed to enroll at least 400 patients; topline results are expected by Q4 2026Evenamide is a ...

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Biotoday announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to ...

SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, ...

Presentation included previously disclosed primary results from the pivotal ARES Phase 3 single-arm trial evaluating MaaT013 (Xervyteg®) in treating refractory severe acute Graft-versus-Host Disease ...